# LLC PHARMACOR PRODUCTION · 99-39 · RUSSIA — FDA import alert red lists: firms subject to detention without physical examination

For LLC PHARMACOR PRODUCTION · 99-39 · RUSSIA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is RUSSIA; product is DIETARY SUPPLEMENT VLADONIX | DIETARY SUPPLEMENT VLADONIX; product code is 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 02/23/2024; address is K. 5 Ofis 247 , Ul. Repischeva D. 14 , Sankt-Peterburg, Sankt-Peterburg g RUSSIA, verified against its source on 2026-09-16.

- **Firm:** LLC PHARMACOR PRODUCTION _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** RUSSIA _(verified: appears in the quote below)_
- **Address:** K. 5 Ofis 247 , Ul. Repischeva D. 14 , Sankt-Peterburg, Sankt-Peterburg g RUSSIA _(verified: appears in the quote below)_
- **Date published:** 02/23/2024 _(verified: appears in the quote below)_
- **Product code:** 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. _(verified: each item appears in the quote below)_
- **Product:** DIETARY SUPPLEMENT VLADONIX | DIETARY SUPPLEMENT VLADONIX _(verified: each item appears in the quote below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of: - Section 403(q) of the Act [21 U.S.C. § 343(q)] in that the presentation of the nutrition information on the labels does not comply with 21 CFR 101.36. - Section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] because the label fails to declare each ingredient by its common or usual name [21 CFR 101.4]. - Section 403(f) of the Act [21 U.S.C. §343(f)] because the product label contains information in two languages but does not repeat all the required information in both languages. - Section 403(r)(6) because the inner booklet insert makes structure/function claims but fails to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e). | The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of: - Section 403(q) of the Act [21 U.S.C. § 343(q)] in that the presentation of the nutrition information on the labels does not comply with 21 CFR 101.36. - Section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] because the label fails to declare each ingredient by its common or usual name [21 CFR 101.4]. - Section 403(f) of the Act [21 U.S.C. §343(f)] because the product label contains information in two languages but does not repeat all the required information in both languages. - Section 403(r)(6) because the inner booklet insert makes structure/function claims but fails to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e). _(verified: each item appears in the quote below)_

## What the source says

> LLC PHARMACOR PRODUCTION Date Published : 02/23/2024 K. 5 Ofis 247 , Ul. Repischeva D. 14 , Sankt-Peterburg, Sankt-Peterburg g RUSSIA 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 02/23/2024 Desc: DIETARY SUPPLEMENT VLADONIX Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of: - Section 403(q) of the Act [21 U.S.C. § 343(q)] in that the presentation of the nutrition information on the labels does not comply with 21 CFR 101.36. - Section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] because the label fails to declare each ingredient by its common or usual name [21 CFR 101.4]. - Section 403(f) of the Act [21 U.S.C. §343(f)] because the product label contains information in two languages but does not repeat all the required information in both languages. - Section 403(r)(6) because the inner booklet insert makes structure/function claims but fails to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e). 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 02/23/2024 Desc: DIETARY SUPPLEMENT VLADONIX Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of: - Section 403(q) of the Act [21 U.S.C. § 343(q)] in that the presentation of the nutrition information on the labels does not comply with 21 CFR 101.36. - Section 403(i)(2) of the Act [21 U.S.C. §343(i)(2)] because the label fails to declare each ingredient by its common or usual name [21 CFR 101.4]. - Section 403(f) of the Act [21 U.S.C. §343(f)] because the product label contains information in two languages but does not repeat all the required information in both languages. - Section 403(r)(6) because the inner booklet insert makes structure/function claims but fails to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e).

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).